Blog > Diagnosis and Treatment >Modern Vein Treatments: The Future of Vascular Care
Modern Vein Treatments: The Future of Vascular Care
18-October-2025Category: Diagnosis and Treatment
Endovenous Laser Ablation (EVLA): The Gold Standard
EVLA represents the pinnacle of modern vein treatment technology. This procedure utilises a
precise 1470nm wavelength laser that specifically targets water molecules within the vein wall.
During the procedure, your physician guides a thin 7Fr catheter through the problematic vein
using ultrasound guidance. The laser delivers carefully controlled thermal energy at 70-120°C,
effectively sealing the vein shut. The entire process takes just 30-45 minutes and boasts an
impressive 98% success rate.
The cost for EVLA in India ranges from ₹45,000 to ₹75,000 per leg, including follow-up care.
Many insurance providers now offer coverage for this treatment, recognising its proven
effectiveness and long-term benefits. Patients usually require only one treatment session,
making it cost-effective compared to repeated surgical interventions.
RFA offers exceptional precision through segmental heating at 120°C using the sophisticated
ClosureFast™ catheter. The procedure methodically treats the vein in 20-second cycles, with
built-in temperature monitoring ensuring optimal results. Taking 45-60 minutes to complete, RFA
achieves a 96% success rate with minimal discomfort.
The treatment costs between ₹40,000 and ₹65,000 per leg in India, making it slightly more
affordable than EVLA. Insurance coverage is similar to EVLA, though approximately 5% of patients
may require a follow-up session for optimal results.
VenaSeal: The Latest Innovation
VenaSeal represents the newest advancement in vein treatment. This revolutionary approach uses
medical-grade N-butyl-2-cyanoacrylate adhesive delivered through a minimal 5Fr catheter. The
adhesive polymerises within 30 seconds of deployment, instantly sealing the vein without
requiring tumescent anaesthesia. The entire procedure takes just 20-30 minutes and maintains a
95% success rate.
At ₹75,000 to ₹1,20,000 per leg, VenaSeal commands a premium price point in India. However,
patients save on compression stockings (₹2,000-4,000) and enjoy the quickest return to normal
activities. Insurance coverage varies, with some providers still considering this cutting-edge
treatment as elective.
Confused about treatment options? Our experts will guide you step by step.
Sclerotherapy: The Spider Vein Solution
Sclerotherapy excels in treating spider veins and small varicose veins. Your physician injects a
specialized solution (either Polidocanol or Sodium Tetradecyl Sulfate) directly into the
problematic veins using ultra-fine needles. The solution irritates the vein walls, causing them
to collapse and eventually fade away. Each 15-30 minute session targets multiple veins, with a
cumulative success rate of 90%.
In India, sclerotherapy costs between ₹15,000-₹25,000 per session, with most patients requiring
3-4 sessions for optimal results. While the per-session cost appears lower, the total investment
might reach ₹45,000-₹75,000 for a complete treatment course. Insurance rarely covers cosmetic
sclerotherapy.
Traditional Surgery: The Legacy Approach
Traditional vein stripping, while still necessary in some cases, involves general anaesthesia
and multiple incisions to physically remove the problematic veins. This 2-3 hour procedure
carries an 85% success rate but demands significant recovery time and poses higher risks of
complications.
The total cost in India ranges from ₹60,000-₹1,00,000 per leg, including hospital stay, surgery,
and anaesthesia costs. While insurance typically covers surgical intervention, the extended
recovery period (2-3 weeks) and higher complication rates make it less appealing for most
patients.
Making Your Choice
While modern treatments may seem more expensive initially, they often prove more economical when
considering: • Minimal time away from work. • Lower risk of complications. • Reduced need for follow-up treatments. • Better long-term results. • Fewer additional medical expenses.
For any unanswered questions, reach out to our support team via
email. We’ll respond as soon as possible to assist you.
For Enquiry
✉
info@avisvascularcentre.com
☎
+ 91 80089 49900
Why do success rates differ between EVLA, RFA, and VenaSeal™ if all close the vein?
−
Although all three treatments aim to close the diseased vein, they use different mechanisms. EVLA
and RFA rely on controlled heat to seal the vein walls, while VenaSeal™ uses a medical adhesive to
bond them shut. Differences in technology, vein anatomy, and patient factors account for slight
variations in success rates, though all are considered highly effective by modern vascular
standards.
Is the higher cost of VenaSeal™ justified compared to EVLA or RFA?
+
VenaSeal™ costs more primarily due to imported adhesive systems and advanced catheter technology.
The higher price often reflects added convenience rather than better outcomes. Patients benefit from
faster recovery, fewer injections, and usually no compression stockings, which can offset indirect
costs such as time off work or post-procedure discomfort.
Why does sclerotherapy require multiple sessions while other treatments do not?
+
Sclerotherapy treats smaller surface veins and spider veins, which are often widespread and
numerous. Each session addresses only a limited number of veins to maintain safety and
effectiveness. In contrast, EVLA, RFA, and VenaSeal™ target larger underlying veins responsible for
reflux, usually allowing complete treatment in a single session.
How do hidden costs impact the overall expense of varicose vein treatment?
+
The procedure cost is only one part of total expenditure. Diagnostic tests, compression stockings,
follow-up visits, medications, and time away from work can significantly influence final costs.
Treatments with faster recovery and fewer repeat sessions may ultimately be more economical despite
a higher upfront price.
Why do insurance companies cover EVLA and RFA more readily than VenaSeal™?
+
EVLA and RFA have been used for a longer time and are widely classified as standard medical
treatments for venous insufficiency. Some insurers still consider VenaSeal™ a newer or premium
option, leading to variable coverage. Insurance approval often depends on medical necessity, policy
terms, and documented vein reflux.
